Rx Farma Limited

Rx Farma Limited, based in London, UK, is a small holding company with an active status, having been incorporated 24 years ago in December 2000. The company employs six people and holds £4,523,562 in assets. It operates from a virtual address, registered with 283 other companies, and is managed by two directors and one owner. As a regular importer, Rx Farma brings in pharmaceutical products, with 29 months of import activity recorded, the latest in February 2025.

The company’s website reveals a Ghanaian pharmaceutical wholesaler and services provider, Rx Pharma, offering a wide range of services to the pharmaceutical industry and healthcare sector. They specialize in distributing branded products, generics, controlled drugs, and medical devices, utilizing a state-of-the-art distribution center. The website also highlights partnerships with hospitals, wholesalers, pharmacies, healthcare professionals, and pharmaceutical companies. It's clear they're focused on providing comprehensive solutions across the supply chain, from sourcing to distribution.

Financially, Rx Farma Limited shows a mixed picture. Current assets have surged by a significant 140%, reaching £4,500,000, while net assets have also dramatically improved, increasing by 250% to £1,000,000. However, trade creditors have also risen substantially, increasing by 140% to £2,600,000. Bank borrowings have also increased by 2,400%, reaching £29,000, and cash reserves fell 30% to £28,000. The company’s small size (meeting two of three criteria for turnover under £10.2m, assets under £5.1m, and fewer than 50 employees) helps it stay agile, but the increase in creditors raises questions. The company's auditor, Blick Rothenberg Audit LLP, issued an unqualified report.

Registered in England/Wales under the registration number 04126111, with a registered address at W1U 7BU, United Kingdom, London, Fifth Floor Watson House, 54-60 Baker Street.

WARNING:The numbers have been rounded for simplicity and may be inaccurate.Please, refer to the latest financial report for verification.